Antidiabetic Drugs: Implications of Price Control Regulations
The global costs of diabetes are estimated to reach $2 trillion by 2030. This is due to the increasing number of type 2 diabetes patients and high drug prices. To reduce the global economic burden, expenditure, and effect of this disease, several policies are being developed in terms of health and social security systems. To devise policy […]